Advertisement

Index by author

January 01, 1983; Volume 224,Issue 1

A

  1. Aarons, R D

    1. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists.
      R D Aarons, A S Nies, J G Gerber and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 1-6;

  2. Abramson, F P

    1. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
      V T Vu, S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 55-61;
    2. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
      S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 62-67;

  3. Arnerić, S P

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

B

  1. Bai, S A

    1. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
      V T Vu, S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 55-61;
    2. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
      S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 62-67;

  2. Bartke, A

    1. The effects of photoperiod on the responses of the hamster vas deferens to nerve stimulation.
      A Johns, R W Steger and A Bartke
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 155-160;

  3. Biollaz, J

    1. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
      M Burnier, J Biollaz, D B Brunner, H Gavras and H R Brunner
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 222-227;

  4. Boyd, M R

    1. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
      S R Slaughter, C N Statham, R M Philpot and M R Boyd
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 252-257;

  5. Brocco, M J

    1. Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation.
      M J Brocco and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 34-39;

  6. Brunner, D B

    1. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
      M Burnier, J Biollaz, D B Brunner, H Gavras and H R Brunner
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 222-227;

  7. Brunner, H R

    1. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
      M Burnier, J Biollaz, D B Brunner, H Gavras and H R Brunner
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 222-227;

  8. Burch, R M

    1. 45Ca fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport.
      R M Burch and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 108-117;

  9. Burnier, M

    1. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
      M Burnier, J Biollaz, D B Brunner, H Gavras and H R Brunner
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 222-227;

  10. Busse, L W

    1. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
      D G Lange, S C Roerig, J M Fujimoto and L W Busse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 13-20;

  11. Buyniski, J P

    1. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
      R L Cavanagh, J J Usakewicz and J P Buyniski
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 171-179;

  12. Bylund, D B

    1. Characterization of adrenergic receptor binding in rat lung: physiological regulation.
      J Latifpour and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 186-192;

C

  1. Catravas, J D

    1. Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal.
      J D Catravas and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 28-33;

  2. Cavanagh, R L

    1. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
      R L Cavanagh, J J Usakewicz and J P Buyniski
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 171-179;

  3. Cheng, S S

    1. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
      L F Tseng, S S Cheng and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 51-54;

  4. Churchill, M C

    1. Effects of trifluoperazine on renin secretion of rat kidney slices.
      P C Churchill and M C Churchill
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 68-72;

  5. Churchill, P C

    1. Effects of trifluoperazine on renin secretion of rat kidney slices.
      P C Churchill and M C Churchill
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 68-72;

  6. Connor, J D

    1. Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
      E G Drust and J D Connor
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 148-154;

  7. Corvasce, M C

    1. Factors influencing the efflux of hepatic glutathione into bile in rats.
      N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;

D

  1. Dasgupta, B R

    1. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
      L L Simpson and B R Dasgupta
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 135-140;

  2. DeWeese, J

    1. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
      R D Spealman, R T Kelleher, S R Goldberg, J DeWeese and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 127-134;

  3. Drust, E G

    1. Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
      E G Drust and J D Connor
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 148-154;

E

  1. Eberle, D E

    1. Factors influencing the efflux of hepatic glutathione into bile in rats.
      N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;

  2. Evans, M A

    1. Role of protein binding in cocaine-induced hepatic necrosis.
      M A Evans
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 73-79;

F

  1. Faison, E P

    1. Pharmacological characterization of purinergic receptors in the rat vas deferens.
      D A Taylor, S Wiese, E P Faison and G G Yarbrough
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 40-45;

  2. Fujimoto, J M

    1. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
      L F Tseng, S S Cheng and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 51-54;
    2. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
      D G Lange, S C Roerig, J M Fujimoto and L W Busse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 13-20;

  3. Furchgott, R F

    1. Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.
      J S Stollak and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 215-221;

G

  1. Gavras, H

    1. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
      M Burnier, J Biollaz, D B Brunner, H Gavras and H R Brunner
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 222-227;

  2. Gebhart, G F

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

  3. Gerber, J G

    1. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists.
      R D Aarons, A S Nies, J G Gerber and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 1-6;

  4. Gillis, C N

    1. Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal.
      J D Catravas and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 28-33;

  5. Goldberg, D M

    1. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
      R D Spealman, R T Kelleher, S R Goldberg, J DeWeese and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 127-134;

  6. Goldberg, S R

    1. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
      R D Spealman, R T Kelleher, S R Goldberg, J DeWeese and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 127-134;

  7. Goodale, D B

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

  8. Goshima, K

    1. Inhibition of ouabain-induced increase in Na content of cultured myocardial cells by quinidine and procainamide.
      K Goshima and S Wakabayashi
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 239-246;

  9. Goto, K

    1. Postjunctional supersensitivity of the smooth muscle of the rat vas deferens induced by calmodulin-antagonizing drugs applied locally to the hypogastric plexus.
      K Goto
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 231-238;

  10. Gudelsky, G A

    1. Effect of yohimbine on rat prolactin secretion.
      H Y Meltzer, M Simonovic and G A Gudelsky
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 21-27;

H

  1. Hahn, R A

    1. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
      R A Hahn, B R MacDonald and M A Martin
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 206-214;

  2. Halliday, S E

    1. The effects of a beta-2 selective adrenergic receptor antagonist (ICI 118,551) on twitch tension in cat soleus muscle.
      H J Smith, S E Halliday and W Rouse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 228-230;

  3. Halushka, P V

    1. 45Ca fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport.
      R M Burch and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 108-117;

  4. Harden, T K

    1. N-Ethylmaleimide-induced alteration in the interaction of agonists with muscarinic cholinergic receptors of rat brain.
      S J Korn, M W Martin and T K Harden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 118-126;

  5. Holtzman, S G

    1. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
      J M White and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 95-99;

J

  1. Johns, A

    1. The effects of photoperiod on the responses of the hamster vas deferens to nerve stimulation.
      A Johns, R W Steger and A Bartke
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 155-160;

K

  1. Kaplowitz, N

    1. Factors influencing the efflux of hepatic glutathione into bile in rats.
      N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;

  2. Kelleher, R T

    1. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
      R D Spealman, R T Kelleher, S R Goldberg, J DeWeese and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 127-134;

  3. Korn, S J

    1. N-Ethylmaleimide-induced alteration in the interaction of agonists with muscarinic cholinergic receptors of rat brain.
      S J Korn, M W Martin and T K Harden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 118-126;

  4. Kuhlenkamp, J

    1. Factors influencing the efflux of hepatic glutathione into bile in rats.
      N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;

L

  1. Lahti, R A

    1. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
      P F Vonvoigtlander, R A Lahti and J H Ludens
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 7-12;

  2. Lakoski, J M

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

  3. Lange, D G

    1. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
      D G Lange, S C Roerig, J M Fujimoto and L W Busse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 13-20;

  4. Latifpour, J

    1. Characterization of adrenergic receptor binding in rat lung: physiological regulation.
      J Latifpour and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 186-192;

  5. Leander, J D

    1. A kappa opioid effect: increased urination in the rat.
      J D Leander
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 89-94;

  6. Lincoln, T M

    1. Effects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta.
      T M Lincoln
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 100-107;

  7. Long, J P

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

  8. Ludens, J H

    1. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
      P F Vonvoigtlander, R A Lahti and J H Ludens
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 7-12;

M

  1. MacDonald, B R

    1. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
      R A Hahn, B R MacDonald and M A Martin
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 206-214;

  2. Martin, M A

    1. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
      R A Hahn, B R MacDonald and M A Martin
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 206-214;

  3. Martin, M W

    1. N-Ethylmaleimide-induced alteration in the interaction of agonists with muscarinic cholinergic receptors of rat brain.
      S J Korn, M W Martin and T K Harden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 118-126;

  4. McMillan, D E

    1. Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation.
      M J Brocco and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 34-39;

  5. Meltzer, H Y

    1. Effect of yohimbine on rat prolactin secretion.
      H Y Meltzer, M Simonovic and G A Gudelsky
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 21-27;

  6. Molinoff, P B

    1. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists.
      R D Aarons, A S Nies, J G Gerber and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 1-6;

  7. Mott, J

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

N

  1. Naes, L

    1. Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.
      T C Westfall, L Naes and C Paul
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 199-205;

  2. Nelson, S H

    1. Interactions of salsolinol and its mono-O-methylated analogs with adrenergic and dopaminergic receptors in the rabbit ear artery.
      S H Nelson and O S Steinsland
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 193-198;

  3. Nies, A S

    1. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists.
      R D Aarons, A S Nies, J G Gerber and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 1-6;

O

  1. O'Donnell, J M

    1. Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.
      J M O'Donnell and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 80-88;

P

  1. Paul, C

    1. Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.
      T C Westfall, L Naes and C Paul
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 199-205;

  2. Petrini, J

    1. Factors influencing the efflux of hepatic glutathione into bile in rats.
      N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;

  3. Philpot, R M

    1. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
      S R Slaughter, C N Statham, R M Philpot and M R Boyd
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 252-257;

R

  1. Riegelman, S

    1. Disposition of caffeine and its metabolites in man.
      D D Tang-Liu, R L Williams and S Riegelman
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 180-185;

  2. Roerig, S C

    1. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
      D G Lange, S C Roerig, J M Fujimoto and L W Busse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 13-20;

  3. Rouse, W

    1. The effects of a beta-2 selective adrenergic receptor antagonist (ICI 118,551) on twitch tension in cat soleus muscle.
      H J Smith, S E Halliday and W Rouse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 228-230;

  4. Ruffolo, R R

    1. Vascular effects of the stereoisomers of dobutamine.
      R R Ruffolo and E L Yaden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 46-50;

S

  1. Seiden, L S

    1. Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.
      J M O'Donnell and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 80-88;

  2. Simonovic, M

    1. Effect of yohimbine on rat prolactin secretion.
      H Y Meltzer, M Simonovic and G A Gudelsky
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 21-27;

  3. Simpson, L L

    1. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
      L L Simpson and B R Dasgupta
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 135-140;

  4. Slaughter, S R

    1. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
      S R Slaughter, C N Statham, R M Philpot and M R Boyd
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 252-257;

  5. Smith, H J

    1. The effects of a beta-2 selective adrenergic receptor antagonist (ICI 118,551) on twitch tension in cat soleus muscle.
      H J Smith, S E Halliday and W Rouse
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 228-230;

  6. Spealman, R D

    1. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
      R D Spealman, R T Kelleher, S R Goldberg, J DeWeese and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 127-134;

  7. Statham, C N

    1. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
      S R Slaughter, C N Statham, R M Philpot and M R Boyd
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 252-257;

  8. Steger, R W

    1. The effects of photoperiod on the responses of the hamster vas deferens to nerve stimulation.
      A Johns, R W Steger and A Bartke
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 155-160;

  9. Steinsland, O S

    1. Interactions of salsolinol and its mono-O-methylated analogs with adrenergic and dopaminergic receptors in the rabbit ear artery.
      S H Nelson and O S Steinsland
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 193-198;

  10. Stollak, J S

    1. Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.
      J S Stollak and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 215-221;

T

  1. Tang-Liu, D D

    1. Disposition of caffeine and its metabolites in man.
      D D Tang-Liu, R L Williams and S Riegelman
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 180-185;

  2. Taylor, D A

    1. Pharmacological characterization of purinergic receptors in the rat vas deferens.
      D A Taylor, S Wiese, E P Faison and G G Yarbrough
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 40-45;

  3. Touloukian, J

    1. Factors influencing the efflux of hepatic glutathione into bile in rats.
      N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;

  4. Tseng, L F

    1. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
      L F Tseng, S S Cheng and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 51-54;

U

  1. Usakewicz, J J

    1. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
      R L Cavanagh, J J Usakewicz and J P Buyniski
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 171-179;

V

  1. Vidrio, H

    1. Baroreflex sensitivity as a determinant of responses to hydralazine in dogs.
      H Vidrio
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 247-251;

  2. Vonvoigtlander, P F

    1. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
      P F Vonvoigtlander, R A Lahti and J H Ludens
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 7-12;

  3. Vu, V T

    1. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
      V T Vu, S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 55-61;

W

  1. Wakabayashi, S

    1. Inhibition of ouabain-induced increase in Na content of cultured myocardial cells by quinidine and procainamide.
      K Goshima and S Wakabayashi
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 239-246;

  2. Westfall, T C

    1. Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.
      T C Westfall, L Naes and C Paul
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 199-205;

  3. White, J M

    1. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
      J M White and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 95-99;

  4. Wiese, S

    1. Pharmacological characterization of purinergic receptors in the rat vas deferens.
      D A Taylor, S Wiese, E P Faison and G G Yarbrough
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 40-45;

  5. Williams, M

    1. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
      S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;

  6. Williams, R L

    1. Disposition of caffeine and its metabolites in man.
      D D Tang-Liu, R L Williams and S Riegelman
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 180-185;

Y

  1. Yaden, E L

    1. Vascular effects of the stereoisomers of dobutamine.
      R R Ruffolo and E L Yaden
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 46-50;

  2. Yarbrough, G G

    1. Pharmacological characterization of purinergic receptors in the rat vas deferens.
      D A Taylor, S Wiese, E P Faison and G G Yarbrough
      Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 40-45;
Back to top

In this issue